Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2017-12-14 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于召开“昆药集团股份有限公司2015年公司债券”2018年度第一次债券持有人会议的通知
Capital/Financing Update Classification · 95% confidence The document is a detailed notice about convening a bondholders' meeting for the 2015 corporate bonds issued by Kunming Pharmaceutical Group Co., Ltd. It includes information about the meeting agenda, voting procedures, and attachments related to the meeting such as the proposal to cancel repurchased shares and change registered capital. The document is not a financial report but a formal notification and procedural document related to bondholder voting. It does not contain financial statements or earnings data, nor is it a simple announcement of a report publication. The content fits best with a Capital/Financing Update (CAP) because it concerns bondholder meetings and corporate bond-related capital matters.
2017-12-14 Chinese
2017年第八次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2017 Eighth Extraordinary General Meeting" of KPC Pharmaceuticals, Inc. It includes detailed agenda, voting procedures, and a specific proposal regarding the cancellation of repurchased shares and change in registered capital. The content is focused on the meeting itself, its organization, and the resolutions to be voted on by shareholders. There are no financial statements or comprehensive financial data presented, nor is this a transcript of a call or a report publication announcement. The document fits the description of materials shared during a shareholders' meeting, specifically an Extraordinary General Meeting (EGM). Therefore, the document is best classified as AGM Information (AGM-R), which includes presentations and materials shared during general meetings.
2017-12-14 Chinese
关于双氢青蒿素片研发项目进入临床试验Ⅱ期的公告
Regulatory Filings Classification · 90% confidence The document is a company announcement regarding the progress of a drug development project entering Phase II clinical trials. It details the research progress, investment, and potential market impact but does not contain financial statements or detailed financial performance data. It is an operational update rather than a financial report or regulatory filing about financial results. The document is relatively short (1873 characters) and serves as a project progress announcement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings related to financial or governance matters. The closest fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2017-12-14 Chinese
关于2017年限制性股票激励计划首次授予的进展公告
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (892 characters) about the progress of the company's 2017 restricted stock incentive plan first grant. It details the number of shares granted, changes in share structure, and references a prior announcement. There is no financial report or detailed financial data, only a disclosure of share capital changes related to stock incentives. This fits the category of Share Issue/Capital Change announcements, as it reports on changes in share capital structure due to restricted stock grants.
2017-12-12 Chinese
八届二十四次监事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed by the Supervisory Board of Kunming Pharmaceutical Group Co., Ltd. It details decisions on adjustments to the 2017 restricted stock incentive plan, verification of incentive recipients' eligibility, and a proposal to cancel repurchased shares and reduce registered capital. The document includes voting results and references to related announcements but does not contain financial statements or detailed financial analysis. It is a corporate governance-related announcement about board resolutions and share capital changes, not a full financial report or earnings release. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management.
2017-12-08 Chinese
独立董事关于聘任刘军锋先生为公司副总裁的独立意见
Board/Management Information Classification · 100% confidence The document is a formal opinion from independent directors regarding the appointment of Mr. Liu Junfeng as the company's vice president. It discusses qualifications, compliance with laws and company bylaws, and the board's approval process. There are no financial statements, earnings data, or regulatory filings beyond this management appointment opinion. The document is short (588 characters) and focuses solely on management appointment, which fits the category of Board/Management Information (MANG).
2017-12-08 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.